Leadership – Page 5

Lonza’s Vision for the Future: A Fireside Chat with New CEO Wolfgang Wienand

10 months ago talkbio0Tagged Biological Factors, CDMO, Cells, gene therapy, Industry, Leadership, Lonza, pharmaceutical manufacturing, Small Molecule, Wolfgang Wienand

Lonza, Wolfgang Wienand, CDMO, Pharmaceutical manufacturing, Biologics, Cell and gene therapy, Small molecules, Leadership transition, Industry outlook

Leadership Changes at Agios and Moderna: Board Resignation and New Marketing Chief

11 months ago talkbio0Tagged Agios, Board Resignation, Changing, Chief, David Schenkein, Drug Industry, Leadership, Mahery, marketing officer, Moderna

David Schenkein, Agios Pharmaceuticals, board resignation, Moderna, Amy Mahery, chief marketing officer, pharmaceutical industry, leadership changes

Pfizer Taps Novartis Veteran Jeffrey Legos to Lead Oncology R&D Efforts

12 months ago talkbio0Tagged Cancer Research, Drug Industry, Jeffrey, Leadership, Legos, Neoplasms, Pfizer, R&D

Pfizer, Jeffrey Legos, oncology, R&D, leadership, cancer research, pharmaceutical industry

Pfizer Appoints Jeffrey Legos as New Chief Oncology Officer, Bolstering Cancer Drug Development Efforts

12 months ago talkbio0Tagged Antineoplastic Agents, Appointments, Drug Industry, Jeffrey, Leadership, Legos, Neoplasms, Novartis, Pfizer

Pfizer, Jeffrey Legos, oncology, cancer drug development, pharmaceutical industry, Novartis, leadership appointment

Julie Kim to Succeed Christophe Weber as Takeda’s CEO in 2026

12 months ago talkbio0Tagged biopharmaceutical company, CEO, Christophe Weber, Drug Industry, Kim, Leadership, succession, Takeda, Transition Mutation

Takeda, Julie Kim, Christophe Weber, CEO succession, pharmaceutical industry, leadership transition, biopharmaceutical company

Kathy High Takes Helm at GV, ARCH-Backed Eye Disease Biotech RhyGaze; Arvinas Sees Leadership Shift

1 year ago talkbio0Tagged Arch of foot, Arvinas, Changing, Granulovirus, GV, Kathy, Leadership, RhyGaze

Kathy High, RhyGaze, GV, ARCH, eye disease biotech, Arvinas, leadership changes

RyCarma Therapeutics Unveils New Leadership and Company Name, Expands Focus on Heart Failure Treatment

1 year ago talkbio0Tagged ARMGO, biotech company, Cardiovascular Diseases, Changing, Heart failure, Leadership, Pharma, Rycals, RyCarma, skeletal muscle diseases

RyCarma Therapeutics, ARMGO Pharma, ryanodine receptor, Rycals, heart failure, cardiovascular diseases, skeletal muscle diseases, biotech company, new leadership, company name change.